Pulmonx Investor Relations Material

Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. The company markets airway clearance therapy systems used to administer medications and mucus-thinning agents to treat cystic fibrosis and other respiratory conditions. Its products include Pulmonx System for Lungs, Lung Flute device, and Combyn device that are used in the subglottic suctioning of mucus from the upper part of the lungs. Pulmonx Corporation was founded in 1995 and is headquartered in Redwood City, California.